Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer. - Malapelle U; Buglioni S; Castellano I; Criscitiello C; Curigliano G; d'Amati G; De Angelis C; de Biase D; Pepe F; Perrone G; Scatena C; Scatolini M; et al. (Pathologica, 2025)